Meridian OHC Partners, LP stated that they own 13.3% of Cyanotech Corp. (NASDAQ:CYAN) in a Schedule 13D disclosure that was filed with the Securities and Exchange Commission (SEC) on Tuesday, October 18th. The investor owns 749,610 shares of the stock worth about $2,953,463. The reporting parties listed on the disclosure included Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, LP and BlueLine Partners, LLC. The disclosure is available through EDGAR at this link.
Shares of Cyanotech Corp. (NASDAQ:CYAN) traded up 1.03% during trading on Tuesday, hitting $3.94. 531 shares of the company’s stock were exchanged. The company’s market cap is $22.26 million. Cyanotech Corp. has a 12-month low of $3.32 and a 12-month high of $6.09. The company has a 50-day moving average of $3.70 and a 200-day moving average of $4.61.
Cyanotech Corp. (NASDAQ:CYAN) last announced its quarterly earnings data on Monday, August 15th. The company reported ($0.12) EPS for the quarter. Cyanotech Corp. had a negative net margin of 15.78% and a negative return on equity of 7.23%. The business had revenue of $7.32 million for the quarter, compared to analyst estimates of $7.60 million. On average, equities analysts expect that Cyanotech Corp. will post ($0.01) earnings per share for the current fiscal year.
About Cyanotech Corp.
Cyanotech Corporation is engaged in the production of high value natural products derived from microalgae. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a nutrient-rich dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.
Want to see what other hedge funds are holding CYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cyanotech Corp. (NASDAQ:CYAN).
Receive News & Ratings for Cyanotech Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech Corp. and related companies with MarketBeat.com's FREE daily email newsletter.